TMIC (The Metabolomics Innovation Centre) was formed in 2011 with the vision of becoming one of the world’s premier metabolomics facilities, offering the widest possible range of cutting-edge, comprehensive, quantitative metabolomic research capabilities and services. It operates as a distributed network platform through an administrative support team and 8 “Nodes” or laboratories distributed among the University of Alberta (UofA – 4 Nodes), the University of Victoria (UVic – 1 Node), McMaster University (1 Node), McGill University (1 Node), and University of Calgary (1 Node).

TMIC’s vision is:

To improve life through the power of metabolomics.

TMIC's mission is:

To catalyze innovation and translate metabolomics from the laboratory to real-world use by creating novel technologies, providing cutting-edge analytic services, sharing foundational data resources, and equipping the next generation of scientists and users. The ultimate goal is to enable the creation of a strong metabolomics industry in Canada and generate social and economic benefits for Canadians.

Board of Directors

The TMIC Board of Directors provides strategic direction and advice to TMIC.

Rachael Scarth (Associate Vice President Operations, University of Victoria)
Gijs Van Rooijen (Chief Scientific Officer, Genome Alberta)
Tony Brooks (CFO, Genome British Columbia)
Walter Dixon (Interim Vice President of Research and Innovation, University of Alberta)
Shelley King (CEO, Natural Products Canada)
Dawn Bell (CSO, Novartis Canada)
Pam Valentine (CEO, Multiple Sclerosis Society of Canada)
Liang Li (Professor, Dept. of Chemistry, University of Alberta)
Jennifer Reid (Operations Manager, TMIC)

Organizational Charts

TMIC Organizational Chart - Management

TMIC Org Chart Management

TMIC Organizational Chart - Funding

TMIC Org Chart Funding

Management and Strategic Plans

TMIC Management Plan December 2019

TMIC Strategic Plan 2019-2024